Does REGORAFENIB Cause Metastases to bone? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Metastases to bone have been filed in association with REGORAFENIB (Stivarga). This represents 0.7% of all adverse event reports for REGORAFENIB.
62
Reports of Metastases to bone with REGORAFENIB
0.7%
of all REGORAFENIB reports
17
Deaths
17
Hospitalizations
How Dangerous Is Metastases to bone From REGORAFENIB?
Of the 62 reports, 17 (27.4%) resulted in death, 17 (27.4%) required hospitalization.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGORAFENIB. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does REGORAFENIB Cause?
Off label use (1,906)
Fatigue (1,530)
Palmar-plantar erythrodysaesthesia syndrome (1,230)
Diarrhoea (1,221)
Decreased appetite (941)
Asthenia (825)
Death (813)
Dysphonia (702)
Nausea (688)
Pain in extremity (686)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which REGORAFENIB Alternatives Have Lower Metastases to bone Risk?
REGORAFENIB vs REGORAFENIB\REGORAFENIB
REGORAFENIB vs RELATLIMAB
REGORAFENIB vs RELPAX
REGORAFENIB vs RELUGOLIX
REGORAFENIB vs REMDESIVIR